Effect of drug-eluting stents on 1-year risk of new-onset atrial fibrillation in patients with acute myocardial infarction treated with percutaneous coronary intervention

The use of a drug-eluting stent (DES) in patients with acute myocardial infarction (AMI) treated with percutaneous coronary intervention is conventional. However, the effect of DES on new-onset atrial fibrillation (AF) after AMI still remains unclear. By using data from Taiwan's National Health...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Fa-Chang, Chang, Ya-Hui, Chen, I-Ming, Liu, Hung-Yi, Lin, Chao-Feng, Chien, Li-Nien
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2020
Materias:
3400
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7447439/
https://www.ncbi.nlm.nih.gov/pubmed/32846847
http://dx.doi.org/10.1097/MD.0000000000021885

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7447439/
https://www.ncbi.nlm.nih.gov/pubmed/32846847
http://dx.doi.org/10.1097/MD.0000000000021885

Ejemplares similares